About Us
Our mission is to provide solutions to assist in candidate advancement challenges through integration of all relevant information. Thus, our customers can make the very best decisions possible about lead selection.
Our commitment is to ensure that the potential of each of your compounds is crystal clear.
CeeTox understands your challenges.
Cost-effective drug discovery and development has never been more important than it is today.
If this is the trend in your company, you are not alone. As R&D spending increases across pharmaceutical and biotech companies, there has been an alarming decrease in the number of FDA-approved drugs.
Led by a scientific staff that has their collective roots in big pharma, CeeTox understands the factors contributing to this trend:
- HTS Screening
- Many drug discovery companies rely on the High Throughput Screening (HTS) model to weed out compounds early in the development process. This enables a large volume of compounds to be evaluated. However, HTS, sometimes referred to as the “Fail Fast, Fail Cheap” model, potentially leads to missed opportunities.
- Compounds that are eliminated early are rarely revisited, despite the promise they might have as future blockbusters.
- Candidate Analysis
- Some drug candidates survive phase I clinical trials, but fail in phase II or III due to efficacy or toxicity issues. Given that these parameters are typically evaluated at a much earlier stage in the development process, the question is raised as to whether the best drug candidates are actually being taken forward.
- More effective predictive tools and decision-making models utilized early on could provide significant R&D cost savings given that the investment in just one successful drug, from discovery through launch is $1.7 billion. A 10% increase in the ability to predict clinical success will result in savings of $100 million.
CeeTox has the solution.
Led by Philip Burton, CeeTox ADME group exists to assure that its pharmaceutical and biotech customers achieve their drug discovery goals.
Whether it is to assist in managing capacity issues or to develop sophisticated multi-criteria optimization approaches, CeeTox can meet your ADME research needs with its high quality data integration.
Our advanced techniques and technologies enable our customers to make informed decisions that save money and dramatically improve the effectiveness of their drug discovery process.